Join us for a recap of the Lhasa Pharmaceutical Science Symposiums held in Colombia and Argentina in March 2026. Participants gained a …
At Lhasa, we believe that the future of science is built on collaboration and the brilliance of the next generation. We are …
Understanding the metabolic fate of compounds is a requirement for safe pharmaceutical development. Whether supporting early-stage drug discovery, conducting impurity qualification for …
In today’s chemical safety landscape, scientists need reliable data to make confident decisions. Challenges in toxicology risk assessments continue to evolve alongside …
Mutagenicity assessment is no longer debated; it is embedded within regulatory science. The more important question today is not whether in silico …
Approaching regulatory compliance with confidence ICH Q3D guidelines require assessing and controlling elemental impurities for regulatory compliant development of drug products. The …